Publication | Open Access

Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy

InflammationMotor DysfunctionAutoimmune DiseaseCytokine Gene TherapyNeurological DisorderMedicineAutoimmunityBrain-immune InteractionRehabilitationNeurologyExperimental Multiple SclerosisMultiple SclerosisNeurorehabilitationNeuroimmunologyNeuroinflammation